Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-001038
Filing Date
2025-03-28
Accepted
2025-03-28 06:34:58
Documents
68
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1668996
2 ex19-1.htm EX-19.1 78632
3 ex23-1.htm EX-23.1 3987
4 ex31-1.htm EX-31.1 11745
5 ex31-2.htm EX-31.2 11747
6 ex32-1.htm EX-32.1 6850
7 ex32-2.htm EX-32.2 6910
  Complete submission text file 0001641172-25-001038.txt   6256359

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE ladx-20241231.xsd EX-101.SCH 37843
9 XBRL CALCULATION FILE ladx-20241231_cal.xml EX-101.CAL 51838
10 XBRL DEFINITION FILE ladx-20241231_def.xml EX-101.DEF 170922
11 XBRL LABEL FILE ladx-20241231_lab.xml EX-101.LAB 386965
12 XBRL PRESENTATION FILE ladx-20241231_pre.xml EX-101.PRE 290005
71 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 811516
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
LadRx Corp (Filer) CIK: 0000799698 (see all company filings)

EIN.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15327 | Film No.: 25781387
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)